chlorpheniramine maleate 2 MG Oral Lozenge
- RxCUI
- 1673791
- RxNorm name
- chlorpheniramine maleate 2 MG Oral Lozenge
- Display name
- Chlorpheniramine (Oral Lozenge)
- Full name
- chlorpheniramine maleate 2 MG Oral Lozenge
- Term type
- SCD
- Status
- Active
- Strength
- 2 mg
- Dose form
- Lozenge
- Route
- Oral Lozenge
- Updated
- 2026-10-21 00:28:16
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 112015
- Active start
- 112015
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
Ingredient, Strength, Base table| Ingredient | Strength | Base | Basis of strength |
|---|
| chlorpheniramine maleate | 2 MG / 1 EACH | chlorpheniramine | chlorpheniramine maleate |
Derived Ingredient Concepts#
RxNav Current And Historical NDCs#
RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.
NDC11, Source, Active table| NDC11 | Source | Active |
|---|
| 59779063815 | rxnav_historical | |
UNII Substances#
UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.
No records found.
Recently Linked DailyMed Labels#
Drug Classes#
Source, Class ID, Class table| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|
| ATC | R06AB | Substituted alkylamines | ATC1-4 | | chlorpheniramine |
| FDASPL | N0000175587 | Histamine-1 Receptor Antagonist | EPC | has_epc | chlorpheniramine |
| MEDRT | D002744 | Chlorpheniramine | CHEM | has_ingredient | chlorpheniramine |
| MEDRT | D002744 | Chlorpheniramine | CHEM | has_ingredient | chlorpheniramine maleate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D004380 | Duodenal Obstruction | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D004380 | Duodenal Obstruction | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D007231 | Infant, Newborn | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D007234 | Infant, Premature | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D007234 | Infant, Premature | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D010437 | Peptic Ulcer | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D010437 | Peptic Ulcer | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D011470 | Prostatic Hyperplasia | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D011470 | Prostatic Hyperplasia | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | chlorpheniramine |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | chlorpheniramine maleate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D001748 | Urinary Bladder Neck Obstruction | DISEASE | ci_with | chlorpheniramine maleate |
| MEDRT | D001748 | Urinary Bladder Neck Obstruction | DISEASE | ci_with | chlorpheniramine |
| MEDRT | D014581 | Urticaria | DISEASE | may_treat | chlorpheniramine maleate |
| MEDRT | D014581 | Urticaria | DISEASE | may_treat | chlorpheniramine |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | chlorpheniramine maleate |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | chlorpheniramine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | chlorpheniramine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | chlorpheniramine maleate |
Properties#
Category, Property, Value table| Category | Property | Value |
|---|
| ATTRIBUTES | ACTIVATED | 11/28/2023 |
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | chlorpheniramine maleate 2 MG Oral Lozenge |
| SOURCES | Source | Gold Standard Alchemy |